|
Associated Network Functions |
Score |
Focus Molecules |
Molecules in Network |
Proteins common to both pools |
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function |
47 |
29 |
26s Proteasome, A2M, APOB, APOE, APOH, C3, C5, CFB, F2, F10, F11, HABP2, ITLN1, LCN2, LTF,MIF, MPO, MUC5AC/MUC5B, PLG,PON1, PRDX1, PROC, PROS1, RBP4, SERPINA1, SERPINC1, SERPING1, SMPD2,TF |
Cellular Assembly and Organization, Cellular Function and Maintenance, Cellular Movement |
40 |
28 |
ACTB, Actin, ACTN1, APOD, C2, C9, CAP1, CD55, CD59, CLU, EN01, Factin, FBLN1, FLNA, FN1, GAPDH, GSN, HBG1, HSP90AB1, Iti, ITIH1, ITIH2, LCP1, MDK, MUC4, NPC2, PGK1, VTN, YWHAZ |
Cancer |
23 |
18 |
AHSG, ALB, APOA2, C1R, C1S, C4BPA, CD163, CFHR1, Fibrinogen, FOLR1, HPX, ITIH4, KLKB1, KNG1, MUC4, ORM1, SERPINA1, SERPINA3 |
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function |
18 |
15 |
AMBP, C1QA, C8A, CD163, CP, HRG, IGHA1, IGHA2, IGHG2, PGD, PGLYRP2, PIGR, PRDX2, TAP2, TUBB4B |
Proteins detected only in the benign pool |
Cellular Movement, Cell-To-Cell Signaling and Interaction, Tissue Development |
43 |
25 |
ANXA1, C5, CD55, CD59, CDH13, CLU, DMBT1, DUOX2, EPS8L2, EZR, FBLN1, GNAI3, GNB2, GSN, MSN, MUC1, MUC4, RAC1, RAP1A, RAP1B, RDX, SDCBP, SPARC,SPP1, THY1 |
Cell Death and Survival |
15 |
12 |
ACE,A NXA4, BAIAP2, C7, CHI3L1, FBLN2, GNA13, IFITM2, PDCD6IP, PROM1, SPARCL1, UBA52 |
Carbohydrate Metabolism, Lipid Metabolism, Small Molecule Biochemistry |
14 |
12 |
APOA2, C4B (includes others), CFB, COL1A2, CST3, GNAQ, HPX,LDL, MUC16, PIGR, QSOX1, TM4SF1 |
Cellular Movement |
14 |
11 |
ADAM9, ANXA2, CTSB, FN1, KRT19, OLFM4, S100A6, SLC9A3R1, SMPDL3B, SNX18, TTR |
Proteins detected only in the malignant pool |
Protein Synthesis, Molecular Transport, Protein Trafficking |
43 |
30 |
ACTB, Actin,ACTR3, CAP1, ENO1, ERCC6, FASN, FGG, FLNA, GAPDH, GNB2L1, HNRNPA1, HNRNPK, HNRNPU, ILF3, KPNB1, MAP4, NCL, NPM1, NUMA1, NUTF2, OTUB1, PKM, PLEC, RPS8, RPS14, SSB, TAGLN2, XPO1, YBX1 |
Cell-To-Cell Signaling and Interaction, Tissue Development, Cellular Movement |
41 |
29 |
ACTN4, ARHGDIA, C5, CALR, CAT, CDH5, CORO1A, EEF1A1, F10, Fibrinogen, FLNB, FN1, GP1BA, GPI, KNG1, LBP, LTF, MBL2, MCAM, MMP9, MPO, NAMPT, PROC, PSMB9, RHOA, RPS3A, SPTAN1, VCL, VCP |
Post-Translational Modification, Protein Folding |
26 |
21 |
ANXA5, CAPZA1, CD44, CRP, CTTN, CYCS, FActin, HNRNPD, Hsp27, Hsp70, Hsp90, HSP90AB1, HSPA5, HSPA8, HSPB1,Igm, LCP1, LDL, NONO, PPIA, RPL6, SOD1, TIMP1,TLN1,TUBA1A, YWHAQ |
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking |
16 |
16 |
APOA4, APOM, ARPC2, DEFA1 (includes others), EEF1A2, GPLD1, HNRNPAB, Iti,ITIH1, ITIH2, LAP3, PSMB8, PSMB9, PSME2, PTGDS, SERPINA3 |
Cell Morphology |
14 |
14 |
APOE, ARHGEF2, C4BPB, CSE1L, EIF3A, FKBP4, HIST1H2BB, LDHB, PARK7, PLTP, RALY, TMSB10/TMSB4X, UCHL1, USP5 |
|